Amarin's Asking ITC To Do FDA's Job, Federal Attorneys Tell Supreme Court

In petition to Supreme Court, Amarin does not assert it makes any fair trade claim "that could be proved without establishing" an FDCA violation, nor does it dispute that its "claims are ultimately premised on allegations that the FDCA was violated," say DoJ solicitor general and ITC counsel.

US Supreme Court building facade with words Equal Justice

The basis for Amarin Corp. PLC's argument that some omega-3 imports are unfair competition for a drug it markets already has been rejected, says the federal government in urging the US Supreme Court to deny the firm's petition to consider its request for a fair trade investigation.

Amarin does not assert in its petition to the Supreme Court that it makes any fair trade claim "that could...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Legal

More from Policy & Regulation